Is Curettage and High-speed Burring Sufficient Treatment for Aneurysmal Bone Cysts?

Wang, Edward H. M.; Marfori, Michael L.; Serrano, Ma Victoria T.; Rubio, Donnel Alexis

doi:10.1007/s11999-014-3809-1

Cited by 53 publications

(57 citation statements)

References 4 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In straightforward cases that do not risk the physis and are relatively easy to access from an anatomic standpoint, intralesional curettage may be preferable in providing definitive treatment of ABC. 46,47 The results of this study support both the effect of doxycycline to target ABC tumor reduction and bony healing. In addition to the recognized effects of doxycycline on giant cell function/apoptosis, MMP inhibition, and VEGF inhibition, our experience supports a primary effect of doxycycline on ABC stromal resulting in necrosis, 39 translating into reduced ABC tumor volume with healing as measured radiographically (P < 0.001).…”

Section: Discussionsupporting

confidence: 68%

Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts

Shiels

Beebe

Mayerson

2016

Journal of Pediatric Orthopaedics

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 68%

Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts

Shiels

Beebe

Mayerson

2016

Journal of Pediatric Orthopaedics

View full text Add to dashboard Cite

show abstract

“…Keçeci et al 21 did not report any significant difference in terms of local recurrence between patients treated with curettage and bone grafting without adjuvants and patients treated with curettage and bone grafting beside burring or phenol usage. On the other hand, using curettage, burring, and bone grafting resulted in lower recurrence rates 15, 22. Also adding electrocautery and phenol in addition to burring have been suggested by the others 23 .…”

Section: Discussionmentioning

confidence: 99%

Can ethanol be used as an adjuvant to extended curettage in order to reduce the recurrence rate of aneurysmal bone cyst?

Solooki

Keikha

Vosoughi

2017

Revista Brasileira de Ortopedia (English Edition)

View full text Add to dashboard Cite

ObjectiveThe best treatment of aneurysmal bone cyst (ABC) is still unclear. This study aimed to evaluate the usefulness of extended curettage and ethanol as an adjuvant to reduce local recurrence of ABCs.MethodsRetrospectively, 68 cases treated for primary and secondary ABCs caused by benign tumors from 2003 to 2013 were enrolled to a follow-up visit between one to ten years after the surgery. The treatment protocol was en-bloc resection, biopsy and curettage, extended curettage consisted of curettage, high-speed burring, ethanol 96%, and electrocauterization (combined four-step alcohol-using approach) followed by defect filling, consecutively.ResultsAmong 36 patients with primary ABCs (16 male, 20 female, mean age of 16 years, range 3–46 years), 29 cases were treated with the combined four-step alcohol-using approach, four patients with resection, and three with biopsy and curettage. Thirty-two cases had secondary ABCs on benign lesions (17 male, 15 female). The recurrence rate was 5.88 in all primary and secondary ABC cases; two recurrences among 29 patients with primary ABCs (6.9%) and one recurrence among the 22 cases with secondary ABCs (4.5%).ConclusionsIt could be suggested that the combined four-step alcohol-using approach may result in a very low recurrence rate of primary and secondary ABC lesions.

show abstract

“…However, Steffner et al reported a 12.5 % postoperative fracture rate with argon beam compared to none in the curettage and burr group, which is postulated as stemming from the argon beam resulting in desiccation and osteonecrosis [35]. The widespread adoption of argon beam coagulation has been stifled as argon beam technology may not be part of the armamentarium of many operating rooms and surgeons may be unfamiliar with the technique [36].…”

Section: Argon Beam Coagulationmentioning

confidence: 99%

Current management of aneurysmal bone cysts

Park

Yang

Sheppard

et al. 2016

Curr Rev Musculoskelet Med

184

259

View full text Add to dashboard Cite

Aneurysmal bone cysts (ABCs) are benign bone lesions arising predominantly in the pediatric population that can cause local pain, swelling, and pathologic fracture. Primary lesions, which constitute roughly two thirds of all ABCs, are thought to be neoplastic in nature, with one third of ABCs arising secondary to other tumors. Diagnosis is made with various imaging modalities, which exhibit characteristic features such as Bfluid-fluid levels,^although biopsy is critical, as telangiectatic osteosarcoma cannot be excluded based on imaging alone. Currently, the standard of care and most widely employed treatment is intralesional curettage. However, tumor recurrence with curettage alone is common and has driven some to propose a multitude of adjuvants with varying efficacy and risk profiles. Historically, therapies such as en bloc resection or radiation therapy were utilized as an alternative to decrease the recurrence rate, but these therapies imposed high morbidity. As a result, modern techniques now seek to simultaneously reduce morbidity and recurrence, the pursuit of which has produced preliminary study into minimally invasive percutaneous treatments and medical management.

show abstract

Is Curettage and High-speed Burring Sufficient Treatment for Aneurysmal Bone Cysts?

Abstract: Level IV, therapeutic study. See the Instructions for Authors for a complete description of levels of evidence.

Cited by 53 publications

References 4 publications

Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts

Percutaneous Doxycycline Treatment of Juxtaphyseal Aneurysmal Bone Cysts

Can ethanol be used as an adjuvant to extended curettage in order to reduce the recurrence rate of aneurysmal bone cyst?

Current management of aneurysmal bone cysts

Contact Info

Product

Resources

About